View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Martijn Den Drijver
  • Martijn Den Drijver

hGears : 2024 not expected to be the year of recovery, TP to €2.80

>Preview 20223 results – preliminary results already published - hGears will report full 2023 results on March 27 at 07.30h CET. However, the company has already released preliminary sales (€113m), EBITDA (€5.6m) and FCF (€-3.1m), which were in line (EBITDA) or better (FCF) than expected. There will be more granular data on sales per segment (E-mobility still the main culprit for the decline in sales, we assume, next to a weak E-tools) as well as the details on workin...

Gospell Digital Technology Co Ltd: 2 directors

Two Directors at Gospell Digital Technology Co Ltd bought 256,500 shares at between 8.600CNY and 8.680CNY. The significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's ...

Ahmed Ben Salem ... (+2)
  • Ahmed Ben Salem
  • Thijs Berkelder

ODDO : Rapport AIE – Une demande revue en hausse, un risque de déficit...

>Croissance de la demande : l’AIE plus optimiste relève ses estimations de 110 kb/j à 1.3 Mb/j - L’AIE vient de publier son rapport mensuel dans lequel elle relève ses estimations de croissance de la demande pour 2024 de 110 kb/j passant ainsi de +1.2 Mb/j à +1.3 Mb/j. Cette révision fait suite à une demande qui surprend à la hausse au T1 24 avec +1.7 Mb/d, ce niveau est plus élevé de 270 kb/j que ce qui était prévu dans le rapport du mois dernier. Ainsi, la demande...

Opko Health Inc: 1 director

A director at Opko Health Inc bought 500,000 shares at 0.874USD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

Ares Management Corp: 1 director

A director at Ares Management Corp sold 113,777 shares at 132.796USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

Meta Platforms Inc: 1 director

A director at Meta Platforms Inc sold 154,824 shares at 490.145USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Cartesian Therapeutics Inc: 1 director

A director at Cartesian Therapeutics Inc bought 1,185,872 shares at 0.562USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

Cor Kluis
  • Cor Kluis

Triodos bank : 2H23 earnings less by higher expenses, final divided hi...

>Conclusion: Earnings less by higher expenses, final divided higher than expected - The 2H23 Triodos Bank (TB) earnings were less than we expected mostly as a result of higher than expected expenses. As we believe the higher expenses are more structural we reduce our future earnings estimates. The final divided over 2023 was materially higher than expected resulting in a final dividend yield of about 10.3% to be paid out on 3 June (ex-div date 20 May). We keep our Ne...

Gartner Inc: 1 director

A director at Gartner Inc sold 1,460 shares at 475.760USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Q2 Holdings Inc: 1 director

A director at Q2 Holdings Inc sold 9,000 shares at 48.490USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

Gland Pharma Ltd: 2 directors

Two Directors at Gland Pharma Ltd sold 8,992 shares at between 1,764.005INR and 1,790.941INR. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...

Groupe Okwind SA: 2 directors

Two Directors at Groupe Okwind SA sold 168,749 shares at 19.700EUR. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

 PRESS RELEASE

EQS-News: Semperit nach Transformationsjahr gestärkt für weiteres Wach...

EQS-News: Semperit AG Holding / Schlagwort(e): Jahresergebnis Semperit nach Transformationsjahr gestärkt für weiteres Wachstum – Ergebnis 2023 noch vom verkauften Medizingeschäft belastet 19.03.2024 / 07:34 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Semperit nach Transformationsjahr gestärkt für weiteres Wachstum – Ergebnis 2023 noch vom verkauften Medizingeschäft belastet   Fortgeführte Geschäftsbereiche mit Umsatz von 721,1 Mio. EUR (–7,5%), EBITDA von 71,8 Mio. EUR (–28,5%) und positivem Ergebnis nach Steuern von 24,9 Mio. E...

 PRESS RELEASE

EQS-News: Semperit strengthened for further growth after transformatio...

EQS-News: Semperit AG Holding / Key word(s): Annual Results Semperit strengthened for further growth after transformation year – earnings 2023 still burdened by sold medical business 19.03.2024 / 07:34 CET/CEST The issuer is solely responsible for the content of this announcement. Semperit strengthened for further growth after transformation year – earnings 2023 still burdened by sold medical business   Continued operations with revenue of EUR 721.1 million (–7.5%), EBITDA of EUR 71.8 million (–28.5%) and positive earnings after tax of EUR 24.9 million (–35.2%) Cost re...

Baptiste Lebacq ... (+2)
  • Baptiste Lebacq
  • Jean-François Granjon

ODDO : Shareholder returns gearing up

>Supercycle and shareholder returns in the oil & gas sector - After several challenging years in which a number of players were in survival mode, the start of a supercycle signals an acceleration in free cash flow generation for certain players and thus in shareholder returns. This is particularly justified as the groups boast strengthened financial situations as well as good visibility thanks to their backlogs. Sector companies are not yet facing a problem of ab...

Marvell Technology Inc: 3 directors

Three Directors at Marvell Technology Inc sold 36,000 shares at between 66.170USD and 67.790USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ...

 PRESS RELEASE

EQS-News: Instone Group achieves upper end of earnings guidance; outlo...

EQS-News: Instone Real Estate Group SE / Key word(s): Annual Results Instone Group achieves upper end of earnings guidance; outlook for 2024 assumes continued solid profitability in a year of transition 19.03.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Instone Group achieves upper end of earnings guidance; outlook for 2024 assumes continued solid profitability in a year of transition Adjusted revenues were nearly stable at EUR 616.0 million in 2023 (2022: EUR 621.0 million), mainly based on construction of sold units progr...

 PRESS RELEASE

EQS-News: Instone Group erreicht oberen Rand der Ergebnisprognose; Pro...

EQS-News: Instone Real Estate Group SE / Schlagwort(e): Jahresergebnis Instone Group erreicht oberen Rand der Ergebnisprognose; Prognose für 2024 geht von weiterhin solider Profitabilität in einem Übergangsjahr aus 19.03.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Instone Group erreicht oberen Rand der Ergebnisprognose; Prognose für 2024 geht von weiterhin solider Profitabilität in einem Übergangsjahr aus Bereinigte Umsatzerlöse in 2023 mit 616,0 Millionen Euro (2022: 621,0 Millionen Euro) nahezu stabil, vor allem in...

Sinan Doganli
  • Sinan Doganli

Bechtle AG : Bechtle manages to successfully navigate through a diffic...

>Full year results slightly above expectations - On Friday 15 March 15, Bechtle released its 2023 annual report. During 2023, Bechtle grew its business volume by +7.0% y-o-y to € 7.8bn and its revenue by +6.5% y-o-y (+3.7% organic) to € 6.4bn (cc +6.0%, ODDO BHF +5.2%). At the same time EBT increased by +6.8% y-o-y to € 374.5m (cc +5.1% ODDO BHF +8.0%) and the EBT expanded to 6.0% (cc 5.8% ODDO BHF 6.1%). Operating cash flow increased to a record high of € 459.0m (p...

Michael B. Schäfer ... (+2)
  • Michael B. Schäfer
  • Stephan Wulf

Bayer : Low valuation remains justified given ongoing uncertainties

>CMD did not deliver what many investors had hoped for - In recent months, many hopes were pinned on the CMD on 5 March, which was expected to provide more clarity on Bayer's strategic direction. In particular, how to tackle the high level of debt that currently limits financial flexibility, e.g. to invest in the weakening pharma pipeline. At the same time, hopes for a major strategic move, such as the separation of the Consumer Health (CH) division, had already faded...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch